Dennis M. Fenton Ph.D.
Director, Chairman of Compensation Committee and Member of Audit Committee,
Dr. Dennis M. Fenton, Ph.D., was an Executive Vice President for Operations and Compliance Officer of Amgen Inc., from May 2003 to July 2007. Dr. Fenton served as an Executive Vice President of Amgen Inc., since March 2000, and its Senior Vice President of Operations from January 1995 to March 2000, Senior Vice President of Sales and Marketing from August 1992 to January 1995, Vice President of Process Development, Facilities and Manufacturing Services from 1991 to 1992, Vice President of Pilot Plant Operations and Clinical Manufacturing from October 1988 to July 1991 and Director of Pilot Plant Operations from 1985 to October 1988.
Dr. Fenton served as a Senior Research Scientist at Pfizer. He joined Amgen in 1982 as a Research Scientist until 2008. He coordinated the design, construction and expansion of manufacturing facilities for Epogen(R) (epoetin alfa) and Neupogen(R) (filgrastim).
He has been the Chairman of Scientific Advisory Board of Althea Technologies, Inc. since June 2012 and has been its Board Observer since June 2012.
He serves as a Director of Javelin Pharmaceuticals, Inc.
Dr. Fenton has been a Director of Xenoport, Inc. since August 2009, Hospira Inc. since July 31, 2012, MedImmune Vaccines, Inc. since March 2000 and Amira Pharmaceuticals, Inc. since April 2008. He has been a Director of Napo Pharmaceuticals, Inc., since May 16, 2011 and Genzyme Corporation since June 2010. He has been Director at Nora Therapeutics, Inc. since March 27, 2014, Genelux Corporation since January 24, 2011 and Dendreon Corp. since November 8, 2011.
Dr. Fenton has been a Director of Kythera Biopharmaceuticals, Inc. since June 2006 and serves as its Lead Independent Director.
He serves as Member of Science Advisory Board at ImmunGene Inc. He serves as a Member of Scientific Advisory Board at Sapphire Energy, Inc. and PBS Biotech, Inc. He has been a Member of Scientific Advisory Board at Althea Technologies, Inc. since June 2012.
He serves as a Trustee of the Keck Graduate Institute, the Board of Regents of California Lutheran University and Biotechnology Institute. He serves as a Director/Trustee at Rutgers University and the Biotechnology Institute. He served as a Director at CytomX Therapeutics, Inc., since October 2008.
He is a Director of Javelin Pharmaceuticals, Inc.
Dr. Fenton has a B.S. degree in Biology from Manhattan College and a Ph.D. in Microbiology from Rutgers University.
# – # – # – # – #
Fenton, Dennis M. [MC1973]
# – # – # – # – #